• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非髓样甲状腺癌的家族聚集性:一项基于挪威5673名甲状腺癌患者一级亲属的人群研究。

Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway.

作者信息

Frich L, Glattre E, Akslen L A

机构信息

Department of Pathology, The Gade Institute, University of Bergen, Norway.

出版信息

Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):113-7.

PMID:11219767
Abstract

The purpose of this study was to estimate the occurrence of familial nonmedullary thyroid cancer (FNMTC) in a large population-based study. Of the 5274 cases of thyroid cancer on record in the Norwegian Cancer Registry between 1960 and 1995, a total of 1025 patients could be identified with verified thyroid cancer, a unique personal identification number, and a link to at least one parent. For patients with nonmedullary carcinoma, 5457 first-degree relatives in 970 families were found, compared with 216 first-degree relatives in 37 families for the medullary cancers. A standardized incidence ratio (SIR) was calculated among the relatives based on rates from the Cancer Registry of Norway. A significantly increased risk of thyroid cancer was found among the 5457 relatives of nonmedullary index cases, both for males [SIR, 5.2; confidence interval (CI), 2.1-10.7; 7 cases] and females (SIR, 4.9; CI, 3.0-7.7; 19 cases). All of these 26 thyroid cancer cases were of the nonmedullary type. Furthermore, an increased risk was found among 4282 relatives of papillary index cases, for both males (SIR, 5.8; CI, 2.1-12.6; 6 cases) and females (SIR, 4.0; CI, 2.1-7.1; 12 cases). The 36 familial papillary thyroid cancer patients had an average age at diagnosis of 43 years. Genetic influence is probably only modest for the familial nonmedullary cases and clearly weaker than for the classic familial type of medullary thyroid cancer.

摘要

本研究的目的是在一项基于大规模人群的研究中评估家族性非髓样甲状腺癌(FNMTC)的发生率。在1960年至1995年期间挪威癌症登记处记录的5274例甲状腺癌病例中,总共可识别出1025例经证实患有甲状腺癌、拥有唯一个人识别码且与至少一位父母有联系的患者。对于非髓样癌患者,在970个家庭中发现了5457名一级亲属,而髓样癌患者在37个家庭中有216名一级亲属。根据挪威癌症登记处的发病率计算亲属中的标准化发病率(SIR)。在非髓样索引病例的5457名亲属中发现甲状腺癌风险显著增加,男性[SIR,5.2;置信区间(CI),2.1 - 10.7;7例]和女性(SIR,4.9;CI,3.0 - 7.7;19例)均如此。这26例甲状腺癌病例均为非髓样类型。此外,在乳头状索引病例的4282名亲属中也发现风险增加,男性(SIR,5.8;CI,2.1 - 12.6;6例)和女性(SIR,4.0;CI,2.1 - 7.1;12例)均是。36例家族性乳头状甲状腺癌患者的平均诊断年龄为43岁。对于家族性非髓样病例,遗传影响可能仅为中等程度,且明显弱于经典的家族性髓样甲状腺癌。

相似文献

1
Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway.非髓样甲状腺癌的家族聚集性:一项基于挪威5673名甲状腺癌患者一级亲属的人群研究。
Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):113-7.
2
Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.在一项大型研究人群中,家族性非髓样甲状腺癌的特征为多灶性和高复发率。
World J Surg. 2002 Aug;26(8):897-902. doi: 10.1007/s00268-002-6615-y. Epub 2002 Apr 30.
3
Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer -- a hospital based study.分化型甲状腺癌患者一级亲属患恶性肿瘤的风险——一项基于医院的研究。
Neoplasma. 2006;53(1):67-72.
4
Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries.非髓样甲状腺癌患者一级亲属的甲状腺癌发病风险:来自五个北欧国家的联合研究。 基于组织学类型和诊断时的年龄。
J Med Genet. 2013 Jun;50(6):373-82. doi: 10.1136/jmedgenet-2012-101412. Epub 2013 Apr 13.
5
Changing trends in incidence and mortality of thyroid cancer in Scotland.苏格兰甲状腺癌发病率和死亡率的变化趋势
Clin Endocrinol (Oxf). 2005 Feb;62(2):156-62. doi: 10.1111/j.1365-2265.2004.02187.x.
6
Papillary thyroid cancer incidence in the volcanic area of Sicily.西西里岛火山地区的甲状腺乳头状癌发病率。
J Natl Cancer Inst. 2009 Nov 18;101(22):1575-83. doi: 10.1093/jnci/djp354. Epub 2009 Nov 5.
7
[Familial nonmedullary thyroid cancer].[家族性非髓样甲状腺癌]
Nihon Rinsho. 2000 Jul;58(7):1519-22.
8
Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study.生殖与月经史及甲状腺乳头状癌风险:旧金山湾区甲状腺癌研究
Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):51-7.
9
Biological behavior and prognosis of familial papillary thyroid carcinoma.家族性甲状腺乳头状癌的生物学行为及预后
Surgery. 2009 Jan;145(1):100-5. doi: 10.1016/j.surg.2008.08.004. Epub 2008 Sep 21.
10
Family history of benign thyroid disease and cancer and risk of thyroid cancer.良性甲状腺疾病和癌症的家族史与甲状腺癌风险
Eur J Cancer. 2004 Mar;40(5):754-60. doi: 10.1016/j.ejca.2003.12.011.

引用本文的文献

1
Polymorphisms in circadian rhythm genes and the risk of differentiated thyroid cancer.昼夜节律基因多态性与分化型甲状腺癌风险
Front Genet. 2025 Jun 4;16:1539090. doi: 10.3389/fgene.2025.1539090. eCollection 2025.
2
Whole Exome-Wide Association Identifies Rare Variants in Associated with Middle Eastern Papillary Thyroid Carcinoma Risk.全外显子组关联研究确定了与中东乳头状甲状腺癌风险相关的罕见变异。
Cancers (Basel). 2023 Aug 24;15(17):4235. doi: 10.3390/cancers15174235.
3
Inherited Thyroid Tumors With Oncocytic Change.具有嗜酸细胞改变的遗传性甲状腺肿瘤。
Front Endocrinol (Lausanne). 2021 Jun 9;12:691979. doi: 10.3389/fendo.2021.691979. eCollection 2021.
4
Association of Parental Consanguinity With Papillary Thyroid Carcinoma: A Case-Control Study.父母近亲结婚与甲状腺乳头癌的关联性:病例对照研究。
J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2769-e2774. doi: 10.1210/clinem/dgab071.
5
Familial non-medullary thyroid cancer: a critical review.家族性非髓样甲状腺癌:批判性综述。
J Endocrinol Invest. 2021 May;44(5):943-950. doi: 10.1007/s40618-020-01435-x. Epub 2020 Oct 6.
6
Oncogenesis of Thyroid Cancer.甲状腺癌的肿瘤发生
Asian Pac J Cancer Prev. 2017 May 1;18(5):1191-1199. doi: 10.22034/APJCP.2017.18.5.1191.
7
Genetic predisposition for nonmedullary thyroid cancer.非髓样甲状腺癌的遗传易感性。
Horm Cancer. 2015 Feb;6(1):13-20. doi: 10.1007/s12672-014-0205-y. Epub 2014 Oct 22.
8
Molecular approaches to thyroid cancer diagnosis.甲状腺癌诊断的分子方法。
Endocr Relat Cancer. 2014 Oct;21(5):T301-13. doi: 10.1530/ERC-14-0166. Epub 2014 May 14.
9
Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.ATM-CHEK2-BRCA1 轴中的变异决定了甲状腺乳头癌的遗传易感性和临床表现。
Genes Chromosomes Cancer. 2014 Jun;53(6):516-23. doi: 10.1002/gcc.22162. Epub 2014 Mar 6.
10
In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma.深入分析正常甲状腺和甲状腺乳头状癌中的 microRNA 转录组。
J Clin Endocrinol Metab. 2013 Aug;98(8):E1401-9. doi: 10.1210/jc.2013-1214. Epub 2013 Jun 19.